XML 77 R66.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Earnings Per Share [Abstract]        
Net Income from Continuing Operations Attributable to Merck & Co., Inc. $ 1,213 $ 2,341 $ 3,958 $ 4,812
Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests 332 661 766 1,409
Net income attributable to Merck & Co., Inc. $ 1,545 $ 3,002 $ 4,724 $ 6,221
Average common shares outstanding 2,533 2,527 2,532 2,531
Common shares issuable 7 9 8 11
Average common shares outstanding assuming dilution 2,540 2,536 2,540 2,542
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders:        
Income from Continuing Operations $ 0.48 $ 0.93 $ 1.56 $ 1.90
Income from Discontinued Operations 0.13 0.26 0.30 0.56
Net Income 0.61 1.19 1.87 2.46
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders:        
Income from Continuing Operations 0.48 0.92 1.56 1.89
Income from Discontinued Operations 0.13 0.26 0.30 0.55
Net Income $ 0.61 $ 1.18 $ 1.86 $ 2.45
Common shares issuable under share-based compensation plans excluded from diluted earnings per common share because the effect would have been antidilutive (in shares) 12 8 11 4